Terumo Overview

  • Year Founded
  • 1921

Year Founded

  • Status
  • Public

  • Employees
  • 31,185

Employees

  • Stock Symbol
  • 4543

Stock Symbol

  • Investments
  • 27

  • Share Price
  • $15.01
  • (As of Friday Closing)

Terumo General Information

Description

Terumo Corp is engaged in the manufacturing and sales of medical devices and pharmaceuticals. The company has divided its business into four segments: "Cardiovascular Company," "Medical Care Solutions Company," "Blood and Cell Technology Company," and "Organ Technologies Business".

Contact Information

Website
www.terumo.com
Formerly Known As
Red Line Thermometer Corporation
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 2-44-1 Hatagaya
  • Shibuya-ku
  • Tokyo, 151-0072
  • Japan
+81
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Stock Exchange
TKS
Corporate Office
  • 2-44-1 Hatagaya
  • Shibuya-ku
  • Tokyo, 151-0072
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Terumo Stock Performance

As of 13-Nov-2026, Terumo’s stock price is $15.01. Its current market cap is $22.1B with 1.48B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.01 $16.01 $12.03 - $16.89 $22.1B 1.48B 5.64M $0.49

Terumo Financials Summary

As of 30-Sep-2026, Terumo has a trailing 12-month revenue of $7.76B.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 21,998,894 20,462,336 27,413,226 26,863,865
Revenue 7,760,951 7,509,555 6,794,648 6,380,123
EBITDA 1,603,964 1,795,781 1,591,141 1,500,590
Net Income 722,018 901,735 767,078 736,204
Total Assets 14,222,797 14,464,300 12,218,419 12,100,443
Total Debt 2,013,397 2,375,834 1,168,372 1,531,867
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Terumo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Terumo‘s full profile, request access.

Request a free trial

Terumo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Terumo Corp is engaged in the manufacturing and sales of medical devices and pharmaceuticals. The company has divided it
Medical Supplies
Tokyo, Japan
31,185 As of 2026

Tokyo, Japan
 

Latham, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Terumo Competitors (51)

One of Terumo’s 51 competitors is Nihon Kohden, a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nihon Kohden Corporation Tokyo, Japan
Angiodynamics Corporation Latham, NY
Edwards Lifesciences Corporation Irvine, CA
Penumbra Formerly VC-backed Alameda, CA
Ambu Corporation Ballerup, Denmark
You’re viewing 5 of 51 competitors. Get the full list »

Terumo Patents

  • 38,839

    Total Documents Applications and Grants

  • Total Patents Families

  • 16,975

    Granted

  • 5,069

    Pending

  • Expiring in next 12 mo

Terumo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026174419-A Program, image processing method, and image processing apparatus. Pending 05-Aug-2026
JP-7819402-B1 Packaging Active 04-Dec-2025
JP-7799885-B1 Peritoneal dialysis solution, peritoneal dialysis solution set, composition used in peritoneal dialysis, and method for performing peritoneal dialysis Active 29-May-2025
WO-2026225431-A1 Drug solution administration device Pending 23-Apr-2025
WO-2026211100-A1 Balloon catheter and method for manufacturing balloon catheter Pending 31-Mar-2025
To view Terumo’s complete patent history, request access »

Terumo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Terumo Investments & Acquisitions (27)

Terumo’s most recent deal was a Merger/Acquisition with OrganOx for . The deal was made on 29-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OrganOx 29-Oct-2025 Merger/Acquisition Therapeutic Devices
WuXi Biologics (Drug Product Plant in Leverkusen, Germany) 30-Jun-2025 Corporate Asset Purchase Buildings and Property
Diabeloop 04-Mar-2024 Later Stage VC Monitoring Equipment
Orchestra BioMed Holdings 05-Jul-2022 Later Stage VC Therapeutic Devices
Diabeloop 02-Jun-2022 Later Stage VC Monitoring Equipment
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Terumo ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Terumo’s complete esg history, request access »

Terumo Exits (6)

Terumo’s most recent exit was on 05-Jul-2022 from Orchestra BioMed Holdings. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Orchestra BioMed Holdings 05-Jul-2022 Completed
  • 7 buyers
Cuorips 12-Apr-2020 Completed
  • 3 buyers
Orchestra BioMed Holdings 07-May-2019 Completed
  • 6 buyers
Cuorips 11-Jul-2018 Completed
  • 3 buyers
Osferion Biomaterials 14-Dec-2006 Secondary Transaction - Private Completed
You’re viewing 5 of 6 exits. Get the full list »

Terumo Affiliates

Subsidiaries (11)

Name Industry Location Year Founded
Terumo Deutschland Eschborn, Austria 2013
Terumo Yamaguchi Kk Yamaguchi, Japan 2011
Terumo China China 2011
Terumo Human Create Co. Tokyo, Japan 2006
Microvention Europe Saint-Germain-En-Laye, France 2002
You’re viewing 5 of 11 affiliates. Get the full list.  »

Terumo FAQs

  • When was Terumo founded?

    Terumo was founded in 1921.

  • Where is Terumo headquartered?

    Terumo is headquartered in Tokyo, Japan.

  • What is the size of Terumo?

    Terumo has 31,185 total employees.

  • What industry is Terumo in?

    Terumo’s primary industry is Medical Supplies.

  • Is Terumo a private or public company?

    Terumo is a Public company.

  • What is Terumo’s stock symbol?

    The ticker symbol for Terumo is 4543.

  • What is the current stock price of Terumo?

    As of 13-Nov-2026 the stock price of Terumo is $15.01.

  • What is the current market cap of Terumo?

    The current market capitalization of Terumo is $22.1B.

  • What is Terumo’s current revenue?

    The trailing twelve month revenue for Terumo is $7.76B.

  • Who are Terumo’s competitors?

    Nihon Kohden, Angiodynamics, Edwards Lifesciences, Penumbra, and Ambu are some of the 51 competitors of Terumo.

  • What is Terumo’s annual earnings per share (EPS)?

    Terumo’s EPS for 12 months was $0.49.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process